Sep 2026· Cancer Discovery· Vol 16, pp. 2172 - 2196· 1 citation· 72 references
Medicine
Abstract
Tumor-secreted ADAMTSL4 activates latent TGFβ1 at muscle cell surfaces, promoting muscle atrophy and fibrosis while also driving adipose tissue wasting, and represents a selective therapeutic target for cancer cachexia.
Cancer cachexia is increasingly recognized as a coordinated, tumor-induced, unsustainable alteration in interorgan communication. Machado and colleagues identify a new molecular mechanism that promotes cachexia, in which tumor-secreted ADAMTSL4 drives tissue wasting by promoting local activation of latent TGFβ1, reveal...
Ying Liu, T. Janowitz· Cancer Discovery· 0 citations
Evidence is provided for a key role of TNFR1, as expressed by malignant cells, in orchestrating a pro-tumor immunosuppressive environment through secondary inflammatory mediators through secondary inflammatory mediators.
Elixabet Bolaños, Lorena Cañas-Zabala, Irene Olivera et al.· Journal of Experimental Medi...· 1 citation
Hepatocellular carcinoma (HCC), a leading cause of cancer death, has a dynamic and heterogeneous tumor microenvironment (TME) that drives progression and therapeutic resistance. We previously elucidated that apoptosis antagonizing transcription factor (AATF) drives angiogenesis in HCC. However, its role in TME remains...
Diwakar Suresh, Akshatha N. Srinivas, Bharathwaaj Gunaseelan et al.· bioRxiv· 0 citations
Lactate, known for its metabolic functions, has recently emerged as a signaling molecule. In a recent issue of Immunity, Guo and colleagues report that lactate is a competitive antagonist of STING and propose an epidermal growth factor receptor (EGFR)-mediated signaling cascade that enhances lactate dehydrogenase A (LD...